Indija - angļu - Central Drugs Standard Control Organization

jackson - thiopental sodium - inj - 500/1000;mg - v.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

jackson allison medical and surgical ltd - nonoxinol 9 25mg - condom with spermicide - 25 mg - active: nonoxinol 9 25mg excipient: macrogol 400

Filipīnas - angļu - FDA (Food And Drug Administration)

jackson pharam'l - ciprofloxacin - film-coated tablet - 500mg

Filipīnas - angļu - FDA (Food And Drug Administration)

jackson pharma'l - omeprazole (as sodium) - capsule - 20mg

Filipīnas - angļu - FDA (Food And Drug Administration)

jackson pharmaceuticals - omeprazole (as sodium) - powder for intravenous infusion - 40mg

Filipīnas - angļu - FDA (Food And Drug Administration)

jackson pharam'l - ciprofloxacin - film-coated tablet - 500mg

Filipīnas - angļu - FDA (Food And Drug Administration)

jackson pharma'l - cefuroxime (as sodium) - powder for injection im/iv - 750mg

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

ranbaxy laboratories limited - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - solution - 10 mg in 5 ml - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the concurrent use of nortriptyline hydrochloride or other tricyclic antidepressants with a monoamine oxidase (mao) inhibitor is contraindicated. hyperpyretic crises, severe convulsions, and fatalities have occurred when similar tricyclic antidepressants were used in such combinations. it is advisable to discontinue the mao inhibitor at least 2 weeks before treatment with nortriptyline hydrochloride is to be started. patients hypersensitive to nortriptyline hydrochloride should not be given the drug. cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. nortriptyline hydrochloride is contraindicated during the acute recovery period after myocardial infarction.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

bryant ranch prepack - clorazepate dipotassium (unii: 63fn7g03xy) (clorazepic acid - unii:d51wo0g0l4) - clorazepate dipotassium tablets, usp are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. clorazepate dipotassium tablets, usp are indicated as adjunctive therapy in the management of partial seizures. the effectiveness of clorazepate dipotassium tablets, usp in long-term management of anxiety, that is, more than 4 months, has not been assessed by systematic clinical studies. long-term studies in epileptic patients, however, have shown continued therapeutic activity. the physician should reassess periodically the usefulness of the drug for the individual patient. clorazepate dipotassium tablets, usp are indicated for the symptomatic relief of acute alcohol withdrawal. clorazepate dipotassium tablets are contraindicated in patients with a known hypersensitivity to the drug and in those with acute narrow angle glaucoma.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

ranbaxy pharmaceuticals inc. - clorazepate dipotassium (unii: 63fn7g03xy) (clorazepic acid - unii:d51wo0g0l4) - clorazepate dipotassium 3.75 mg - clorazepate dipotassium tablets, usp are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. clorazepate dipotassium tablets, usp are indicated as adjunctive therapy in the management of partial seizures. the effectiveness of clorazepate dipotassium tablets, usp in long-term management of anxiety, that is, more than 4 months, has not been assessed by systematic clinical studies. long-term studies in epileptic patients, however, have shown continued therapeutic activity. the physician should reassess periodically the usefulness of the drug for the individual patient. clorazepate dipotassium tablets, usp are indicated for the symptomatic relief of acute alcohol withdrawal. clorazepate dipotassium tablets are contraindicated in patients with a known hypersensitivity to the drug and in those with acute narrow angle glaucoma.